IL6 and cancer: Moreover, TLR signaling by invading pathogens or during cancer-associated inflammation, activate Rac1 and Cdc42 which leads to Nuclear Factor kB (NFκB) transcriptional activity and secretion of inflammatory cytokines such as interleukin-6 (IL-6) (20).